Article info
PDFCommentary
Counterpoint: stenting for idiopathic intracranial hypertension should be trialed
- Correspondence to Dr Colin P Derdeyn, Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA; colin-derdeyn{at}uiowa.edu
Citation
Counterpoint: stenting for idiopathic intracranial hypertension should be trialed
Publication history
- Accepted April 11, 2023
- First published June 21, 2023.
Online issue publication
October 12, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.